{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:49:22Z","timestamp":1782121762052,"version":"3.54.5"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>\n                    The efficacy and adverse reactions of Maren Runchang Pills among patients of different genders remain unclear. This study aims to analyze the efficacy and safety differences of Maren Runchang Pills in patients of different genders, providing a basis for the implementation of gender-precise treatment in clinical practice. Gender-stratified analysis was adopted to include constipation-predominant irritable bowel syndrome (IBS-C) patients who met the syndrome of intestinal heat and accumulation. The efficacy and safety of Maren Runchang Pills were evaluated after 4 weeks of treatment. The main evaluation indicators include the complete spontaneous bowel movement response rates, visual analogue scale scores for abdominal pain and distension, traditional Chinese medicine syndrome scores, irritable bowel syndrome-symptom severity scale\/irritable bowel syndrome-quality of life scale scores, and safety indicators. A total of 126 patients were included, among whom 101 were female and 25 were male. After 4 weeks of treatment, the proportion of female patients with a complete spontaneous bowel movement response rate of \u226575% was significantly higher than that of male patients (71.29% vs 48%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0270), and the improvement in abdominal distension visual analogue scale score was also significantly better in females (decrease of 2.78 points vs 1.84 points,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0199). However, the total score of traditional Chinese medicine syndromes in male patients was higher than that in female patients (7.08 points vs 5.09 points,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0341). There were no statistically significant differences in the scores of the irritable bowel syndrome-symptom severity scale, irritable bowel syndrome-quality of life scale and safety indicators between the 2 groups. Maren Runchang Pills can effectively alleviate the constipation symptoms of patients with IBS-C, and the therapeutic effect is even better in female patients. The research results support considering gender factors in the clinical treatment of IBS-C to achieve individualized and precise intervention.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048549","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:00:53Z","timestamp":1777629653000},"page":"e48549","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gender differences in the efficacy and safety of Maren Runchang Pills in treating constipation-predominant irritable bowel syndromes: A gender-stratified analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Huijuan","family":"Guo","sequence":"first","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Jiao","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Statistics Department, Beijing Zhuoyue Future International Pharmaceutical Science and Technology Development Co., Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Li","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Jin","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Yan","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manping","family":"Guo","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Beijing Tongrentang Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China"},{"name":"Beijing Tongrentang Medical Care Investment Co., Ltd., Beijing Tongrentang Research Institute, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.medcli.2021.04.029","article-title":"Irritable bowel syndrome.","volume":"158","author":"Sebasti\u00e1n Domingo","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.3748\/wjg.v20.i22.6759","article-title":"Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.","volume":"20","author":"Saha","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1056\/NEJMra1607547","article-title":"Irritable bowel syndrome.","volume":"376","author":"Ford","year":"2017","journal-title":"N Engl J Med"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"e14796","DOI":"10.1111\/nmo.14796","article-title":"Prevalence of extra-intestinal symptoms according to irritable bowel syndrome subtype.","volume":"36","author":"Pereyra","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1038\/s41467-024-48739-7","article-title":"Exposure to environmental pollutants selects for xenobiotic-degrading functions in the human gut microbiome.","volume":"15","author":"De Filippis","year":"2024","journal-title":"Nat Commun"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"e70547","DOI":"10.1002\/jbt.70547","article-title":"DC09, derivative of 3-(2-hydroxy-5-methoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one attenuates nonalcoholic fatty liver disease by targeting PI3K\/Akt pathway: insights from in-vivo zebrafish model and in-vitro HepG2 cell.","volume":"39","author":"Dharshan","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"issue":"Pt 1","key":"R7-20260622","doi-asserted-by":"crossref","first-page":"117526","DOI":"10.1016\/j.bcp.2025.117526","article-title":"Protective role of dibenzylideneacetone derivative (MBK2) against diabetic pathophysiology via PTGS2-PGE2 signaling modulation and redox homeostasis.","volume":"243","author":"Pohokar","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"100635","DOI":"10.1016\/j.microb.2025.100635","article-title":"Hepatoprotective protein pigment complex phycocyanin from Spirulina maxima and its potential antimicrobial, oxidative stress-modulating effects.","volume":"10","author":"Priyanka","year":"2026","journal-title":"The Microbe"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"150567","DOI":"10.1016\/j.ijbiomac.2026.150567","article-title":"Preparation, characterization and protective effect of pectin\/alginate nanoparticles loaded with propolis extract against doxorubicin-induced testicular toxicity.","volume":"345","author":"Abd Elhamid","year":"2026","journal-title":"Int J Biol Macromol"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ptr.8364","article-title":"Epigenetic effects of natural products in inflammatory diseases: recent findings.","volume":"39","author":"Yao","year":"2025","journal-title":"Phytother Res"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"143295","DOI":"10.1016\/j.chemosphere.2024.143295","article-title":"Biochemical processes mediating neurotoxicity induced by synthetic food dyes: a review of current evidence.","volume":"364","author":"Damotharan","year":"2024","journal-title":"Chemosphere"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"709","DOI":"10.20452\/pamw.16067","article-title":"Recent advances in the treatment of irritable bowel syndrome.","volume":"131","author":"Bonetto","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5056\/jnm18082","article-title":"Sex-gender differences in irritable bowel syndrome.","volume":"24","author":"Kim","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ajg.2012.131","article-title":"Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.","volume":"107","author":"Lovell","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"334","DOI":"10.15403\/jgld-3828","article-title":"Epidemiology of irritable bowel syndrome in Albania.","volume":"30","author":"Galica","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.genm.2010.06.007","article-title":"Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea.","volume":"7","author":"Herman","year":"2010","journal-title":"Gend Med"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ajg.2010.58","article-title":"Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.","volume":"105","author":"Schmulson","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"8612189","DOI":"10.1155\/2017\/8612189","article-title":"Treatment algorithm for chronic idiopathic constipation and constipation-predominant irritable bowel syndrome derived from a Canadian national survey and needs assessment on choices of therapeutic agents.","volume":"2017","author":"Tse","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian association of gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS).","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"e5929","DOI":"10.1002\/bmc.5929","article-title":"Ultra-high-performance liquid chromatography-mass spectrometry combined with molecular docking and molecular dynamics simulation reveals the source of bitterness in the traditional Chinese medicine formula Runchang-Tongbian.","volume":"38","author":"Li","year":"2024","journal-title":"Biomed Chromatogr"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13020-021-00530-2","article-title":"Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.","volume":"16","author":"Zheng","year":"2021","journal-title":"Chin Med"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"154350","DOI":"10.1016\/j.phymed.2022.154350","article-title":"Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2\/PERK-eIF2\u03b1-ATF4 signaling pathway.","volume":"107","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"120906","DOI":"10.1016\/j.jep.2025.120906","article-title":"Multitarget actions of TongXie-Ning granules against the gut dysfunctions of diarrhea-predominant irritable bowel syndrome.","volume":"357","author":"Zhang","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"R24-20260622","first-page":"e65421","article-title":"Prevalence of irritable bowel syndrome (IBS) in the Arab World: a systematic review.","volume":"16","author":"Almansour","year":"2024","journal-title":"Cureus"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1002\/fsn3.4477","article-title":"Comparing lactic acid bacteria biodiversity in irritable bowel syndrome and healthy gut microbiota.","volume":"12","author":"Azimi","year":"2024","journal-title":"Food Sci Nutr"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"e13998","DOI":"10.1111\/nmo.13998","article-title":"Visceral hypersensitivity is together with psychological distress and female gender associated with severity of IBS-like symptoms in quiescent ulcerative colitis.","volume":"33","author":"Mavroudis","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jech.47.4.331","article-title":"Intestinal transit time in the population calculated from self made observations of defecation.","volume":"47","author":"Probert","year":"1993","journal-title":"J Epidemiol Community Health"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5056\/jnm21002","article-title":"Pathophysiological commonality between irritable bowel syndrome and metabolic syndrome: role of corticotropin-releasing factor-toll-like receptor 4-proinflammatory cytokine signaling.","volume":"28","author":"Nozu","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"e14558","DOI":"10.1111\/nmo.14558","article-title":"Epigenetic mechanisms underlying stress-induced visceral pain: Resilience versus vulnerability in a two-hit model of early life stress and chronic adult stress.","volume":"35","author":"Louwies","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"908911","DOI":"10.3389\/fnmol.2022.908911","article-title":"Upregulation of Netrin-1 in the hippocampus mediates the formation of visceral hypersensitivity induced by maternal separation.","volume":"15","author":"Wang","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2017.07.036","article-title":"Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome.","volume":"471","author":"Jacenik","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"12 Suppl","key":"R32-20260622","first-page":"S602","article-title":"Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women?","volume":"101","author":"Ouyang","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R33-20260622","doi-asserted-by":"crossref","first-page":"e14770","DOI":"10.1111\/nmo.14770","article-title":"Placebo response to sham electroacupuncture in patients with chronic functional constipation: a secondary analysis.","volume":"36","author":"Xiong","year":"2024","journal-title":"Neurogastroenterol Motil"},{"key":"R34-20260622","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejpain.2004.03.001","article-title":"Visceral pain: gender differences in response to experimental and clinical pain.","volume":"8","author":"Arendt-Nielsen","year":"2004","journal-title":"Eur J Pain"},{"key":"R35-20260622","doi-asserted-by":"crossref","first-page":"G543","DOI":"10.1152\/ajpgi.00233.2023","article-title":"NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons.","volume":"326","author":"King","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R36-20260622","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41423-023-01054-5","article-title":"The role of cellular and molecular neuroimmune crosstalk in gut immunity.","volume":"20","author":"Yang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R37-20260622","first-page":"277","article-title":"Irritable bowel syndrome: a hallmark of psychological distress in women?","volume":"15","author":"Marano","year":"2025","journal-title":"Life (Basel)"},{"key":"R38-20260622","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12876-024-03153-7","article-title":"Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea.","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R39-20260622","doi-asserted-by":"crossref","first-page":"1275041","DOI":"10.3389\/fphar.2023.1275041","article-title":"Central and peripheral analgesic active components of triterpenoid saponins from Stauntonia chinensis and their action mechanism.","volume":"14","author":"Gong","year":"2023","journal-title":"Front Pharmacol"},{"key":"R40-20260622","doi-asserted-by":"crossref","first-page":"115392","DOI":"10.1016\/j.jep.2022.115392","article-title":"Effective components and mechanism analysis of anti-platelet aggregation effect of Justicia procumbens L.","volume":"294","author":"Liu","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"R41-20260622","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00404-017-4363-3","article-title":"Gender-based personalized pharmacotherapy: a systematic review.","volume":"295","author":"Islam","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"R42-20260622","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41467-023-35808-6","article-title":"Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes.","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"R43-20260622","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1124\/dmd.122.001011","article-title":"Cytochrome P450 and other drug-metabolizing enzymes as therapeutic targets.","volume":"51","author":"Foti","year":"2023","journal-title":"Drug Metab Dispos"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:09:38Z","timestamp":1782119378000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":43,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048549","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2026-01-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}